Cardiac stem cells, a specialized class of stem cells, exhibit an extraordinary capacity to transform into diverse cell types within the heart, positioning them as a pivotal focus in the realm of regenerative medicine for cardiovascular diseases. Nestled within the heart tissue, these unique cells play a vital role in preserving cardiac function and facilitating repair. What sets cardiac stem cells apart is their distinct regenerative potential, unlike mature heart cells with limited regenerative abilities. These cells hold the promise of generating new heart cells, including cardiomyocytes, endothelial cells, and smooth muscle cells. Scientists are actively investigating the therapeutic possibilities of leveraging these cells to mend damaged heart tissue resulting from conditions such as heart attacks or heart failure. The goal is to stimulate the growth and differentiation of cardiac stem cells, ultimately fostering heart regeneration and enhancing overall cardiac function. Ongoing research endeavors in this domain aspire to unlock the full spectrum of potential inherent in cardiac stem cells, opening up new and promising avenues for innovative approaches in cardiovascular treatment and the eventual realization of regenerative therapies for heart disorders.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt